S
Sage Therapeutics D
D
SAGE
7.29000
USD
-0.19
(-2.47%)
مغلق
حجم التداول
37,199
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
456,504,859
الأخبار المقالات
العنوان: Sage Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; alsotargeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment ofpostpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.